• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mini-review: diabetic renal complications, a potential stinky remedy.迷你综述:糖尿病肾脏并发症,一种潜在的有效疗法。
Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F119-22. doi: 10.1152/ajprenal.00299.2015. Epub 2015 Nov 4.
2
MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.基质金属蛋白酶-9和N-甲基-D-天冬氨酸受体介导的糖尿病性肾血管重塑及肾功能障碍机制:硫化氢是关键调节因子。
Nitric Oxide. 2015 Apr 30;46:172-85. doi: 10.1016/j.niox.2015.02.003. Epub 2015 Feb 7.
3
Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.硫化氢缺乏与糖尿病肾重塑:基质金属蛋白酶-9 的作用。
Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1365-78. doi: 10.1152/ajpendo.00604.2012. Epub 2013 Apr 30.
4
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.硫化氢:治疗糖尿病肾病的最新进展和展望。
Molecules. 2019 Aug 6;24(15):2857. doi: 10.3390/molecules24152857.
5
Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy.硫化氢调节 SIRT1 并抑制糖尿病肾病中的氧化应激。
Mol Cell Biochem. 2019 Jul;457(1-2):1-9. doi: 10.1007/s11010-019-03506-x. Epub 2019 Feb 18.
6
Diabetic nephropathy: A potential savior with 'rotten-egg' smell.糖尿病肾病:一种带有“臭鸡蛋”气味的潜在救星。
Pharmacol Rep. 2017 Apr;69(2):331-339. doi: 10.1016/j.pharep.2016.11.004. Epub 2016 Nov 11.
7
Protective effect of hydrogen sulfide on the kidney (Review).硫化氢对肾脏的保护作用(综述)。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12335. Epub 2021 Aug 9.
8
GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.GYY4137 通过调节维甲酸 X 受体信号转导调节糖尿病肾脏细胞外基质代谢。
Biomolecules. 2021 Oct 7;11(10):1477. doi: 10.3390/biom11101477.
9
Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.糖尿病肾病慢性血液透析患者中低浓度硫化氢与动脉粥样硬化的相关性
Blood Purif. 2014;38(3-4):188-94. doi: 10.1159/000368883. Epub 2014 Dec 16.
10
Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy.新型硫化氢释放化合物S-炔丙基半胱氨酸可预防链脲佐菌素诱导的糖尿病肾病。
Biochem Biophys Res Commun. 2016 May 13;473(4):931-938. doi: 10.1016/j.bbrc.2016.03.154. Epub 2016 Apr 4.

引用本文的文献

1
The CLCA1/TMEM16A/Cl- current axis associates with H2S deficiency in diabetic kidney injury.CLCA1/TMEM16A/氯离子电流轴与糖尿病肾损伤中硫化氢缺乏相关。
JCI Insight. 2025 Jan 9;10(1):e174848. doi: 10.1172/jci.insight.174848.
2
Advances of Iron and Ferroptosis in Diabetic Kidney Disease.铁与铁死亡在糖尿病肾病中的研究进展
Kidney Int Rep. 2024 Apr 3;9(7):1972-1985. doi: 10.1016/j.ekir.2024.04.012. eCollection 2024 Jul.
3
Diabetic Nephropathy and Gaseous Modulators.糖尿病肾病与气体调节剂
Antioxidants (Basel). 2023 May 12;12(5):1088. doi: 10.3390/antiox12051088.
4
Effects of Sodium Thiosulfate During Resuscitation From Trauma-and-Hemorrhage in Cystathionine-γ-Lyase Knockout Mice With Diabetes Type 1.硫代硫酸钠对1型糖尿病胱硫醚-γ-裂解酶基因敲除小鼠创伤性出血复苏的影响
Front Med (Lausanne). 2022 Apr 29;9:878823. doi: 10.3389/fmed.2022.878823. eCollection 2022.
5
GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.GYY4137 通过调节维甲酸 X 受体信号转导调节糖尿病肾脏细胞外基质代谢。
Biomolecules. 2021 Oct 7;11(10):1477. doi: 10.3390/biom11101477.
6
Hydrogen Sulfide and the Kidney.硫化氢与肾脏。
Adv Exp Med Biol. 2021;1315:17-50. doi: 10.1007/978-981-16-0991-6_2.
7
Hydrogen sulfide ameliorates aging-associated changes in the kidney.硫化氢改善肾脏与衰老相关的变化。
Geroscience. 2018 Apr;40(2):163-176. doi: 10.1007/s11357-018-0018-y. Epub 2018 May 1.
8
EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress.表皮生长因子受体(EGFR)抑制通过降低活性氧(ROS)和内质网应激来减轻糖尿病肾病。
Oncotarget. 2017 May 16;8(20):32655-32667. doi: 10.18632/oncotarget.15948.

本文引用的文献

1
Hydrogen sulfide in pharmacology and medicine--An update.药理学与医学中的硫化氢——最新进展
Pharmacol Rep. 2015 Jun;67(3):647-58. doi: 10.1016/j.pharep.2015.01.005. Epub 2015 Jan 22.
2
A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients.一种新型硫化氢前药SG1002可提高心力衰竭患者体内硫化氢和一氧化氮的生物利用度。
Cardiovasc Ther. 2015 Aug;33(4):216-26. doi: 10.1111/1755-5922.12128.
3
Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes.他达拉非整合一氧化氮-硫化氢信号传导以抑制高糖诱导的足细胞基质蛋白合成。
J Biol Chem. 2015 May 8;290(19):12014-26. doi: 10.1074/jbc.M114.615377. Epub 2015 Mar 9.
4
MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.基质金属蛋白酶-9和N-甲基-D-天冬氨酸受体介导的糖尿病性肾血管重塑及肾功能障碍机制:硫化氢是关键调节因子。
Nitric Oxide. 2015 Apr 30;46:172-85. doi: 10.1016/j.niox.2015.02.003. Epub 2015 Feb 7.
5
Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.糖尿病肾病慢性血液透析患者中低浓度硫化氢与动脉粥样硬化的相关性
Blood Purif. 2014;38(3-4):188-94. doi: 10.1159/000368883. Epub 2014 Dec 16.
6
Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.通过过表达胱硫醚γ-裂解酶(CSE)基因实现硫化氢的抗动脉粥样硬化作用。
PLoS One. 2014 Nov 14;9(11):e113038. doi: 10.1371/journal.pone.0113038. eCollection 2014.
7
Nitric oxide in the normal kidney and in patients with diabetic nephropathy.正常肾脏及糖尿病肾病患者体内的一氧化氮
J Nephrol. 2015 Jun;28(3):257-68. doi: 10.1007/s40620-014-0136-2. Epub 2014 Sep 13.
8
Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model.硫化氢可缓解链脲佐菌素诱导的糖尿病大鼠模型中的糖尿病肾病。
J Biol Chem. 2014 Oct 17;289(42):28827-34. doi: 10.1074/jbc.M114.596593. Epub 2014 Aug 27.
9
Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activated protein kinase signaling.硫化氢通过肝激酶B1-单磷酸腺苷激活的蛋白激酶信号通路减轻高血糖重塑。
Biochim Biophys Acta. 2014 Dec;1843(12):2816-26. doi: 10.1016/j.bbamcr.2014.08.005. Epub 2014 Aug 13.
10
Molecular mechanisms of diabetic kidney disease.糖尿病肾病的分子机制。
J Clin Invest. 2014 Jun;124(6):2333-40. doi: 10.1172/JCI72271. Epub 2014 Jun 2.

迷你综述:糖尿病肾脏并发症,一种潜在的有效疗法。

Mini-review: diabetic renal complications, a potential stinky remedy.

作者信息

Sen Utpal, Pushpakumar Sathnur

机构信息

Department of Physiology, University of Louisville School of Medicine, Louisville, Kentucky

Department of Physiology, University of Louisville School of Medicine, Louisville, Kentucky.

出版信息

Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F119-22. doi: 10.1152/ajprenal.00299.2015. Epub 2015 Nov 4.

DOI:10.1152/ajprenal.00299.2015
PMID:26538437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4719040/
Abstract

Chronic kidney disease is associated with vasculitis and is also an independent risk factor for peripheral vascular and coronary artery disease in diabetic patients. Despite optimal management, a significant number of patients progress toward end-stage renal disease (ESRD), a suggestion that the disease mechanism is far from clear. A reduction in hydrogen sulfide (H2S) has been suggested to play a vital role in diabetic vascular complications including diabetic nephropathy (DN). This mini-review highlights the recent findings on the role of H2S in mitigating abnormal extracellular matrix metabolism in DN. A discussion on the development of the newer slow-releasing H2S compounds and its therapeutic potential is also included.

摘要

慢性肾脏病与血管炎相关,也是糖尿病患者外周血管疾病和冠状动脉疾病的独立危险因素。尽管进行了最佳管理,但仍有相当数量的患者进展为终末期肾病(ESRD),这表明该疾病的发病机制尚不清楚。有研究表明,硫化氢(H2S)减少在包括糖尿病肾病(DN)在内的糖尿病血管并发症中起关键作用。本综述重点介绍了H2S在减轻DN异常细胞外基质代谢中作用的最新研究结果。还讨论了新型缓释H2S化合物的开发及其治疗潜力。